Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found four records

$176,000.00

Oct 1, 2025

For-profit organization

Agreement:

Inflammation – biomarkers of health, aging, stress and fatigue, and anti-inflammatory cannabis formulations

Agreement Number:

1039059

Duration: from Oct 1, 2025 to Mar 17, 2027
Description:

Pathway Rx is engaged in the development of natural based pharmaceutical products for prevention and treatment of inflammation.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program
Location: Calgary, Alberta, CA T3H 4Z2

$60,000.00

Jan 1, 2025

For-profit organization

Agreement:

AI Assist for software developers

Agreement Number:

1028182

Duration: from Jan 1, 2025 to Oct 8, 2025
Description:

The Firm develops bioinformatics- and ML-based approaches to analysis of large diverse data sets, identifying epigenetic signatures of health and disease. This project is the development of ML-based approach for predicting the best treatment option for inflammatory conditions and cancer.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Calgary, Alberta, CA T3H 4Z2

$75,000.00

Sep 1, 2024

For-profit organization

Agreement:

Implementing Biomarkers for diagnostics and therapeutic evaluation and monitoring

Agreement Number:

1023399

Duration: from Sep 1, 2024 to Jun 30, 2025
Description:

Pathway Rx is developing bioinformatics processes that allow to analyze and integrate multiple sources of information – genomics, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics. The outcome will be the diagnostic and therapeutic efficiency software, allowing biomarkers-based diagnosis of various conditions and the ability to monitor the efficiency of treatments.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Calgary, Alberta, CA T3H 4Z2

$463,000.00

Nov 1, 2021

For-profit organization

Agreement:

Medical applications of cannabis and fungal extracts

Agreement Number:

981927

Duration: from Nov 1, 2021 to Feb 29, 2024
Description:

Development of novel botanical and fungal extracts for treatment inflammation in various human tissues. Using a combination of in vitro and in vivo assays, including single cell cultures, 3D tissues and mice/rat models, Pathway will develop formulations for treatment and prevention of inflammation-related conditions.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Calgary, Alberta, CA T3H 4Z2